1.Clinical Characteristics of Polypoidal Choroidal Vasculopathy Associated with Chronic Central Serous Chorioretionopathy.
Korean Journal of Ophthalmology 2012;26(1):15-20
PURPOSE: To investigate the clinical characteristics of polypoidal choroidal vasculopathy (PCV) associated with chronic central serous chorioretinopathy (CSC). METHODS: We retrospectively reviewed the medical records of 246 PCV patients (283 eyes) between July 2004 and August 2009 and investigated the clinical characteristics of the PCV patients who had specific fundus findings of chronic CSC. RESULTS: Among PCV patients, 13 eyes (4.6%) of 13 PCV patients (5.3%) had fundus findings of chronic CSC. All of the PCV lesions had a solitary polyp located outside the atrophic retina, predominantly in the macular area (84.6%), most showed an exudative pattern (69.2%) and there were a few that showed a hemorrhagic pattern (30.8%). All of the lesions were smaller than 1 disc diameter. Most of the PCV lesions (76.9%) were cured with less than two treatments in a short period of 6.4 +/- 1.9 months; however, visual acuity deteriorated (61.5%) or was not changed (30.8%) in most of the cases. CONCLUSIONS: The PCV associated with chronic CSC had several clinical features such as a small exudative retinal lesion with a solitary polyp and frequent involvement of the macular area. Even though there was poor visual outcome due to the atrophic change, all of the PCV lesions were easily resolved in a short period with a simple treatment course and no recurrence.
Aged
;
Choroid/*blood supply
;
Choroid Diseases/*complications/diagnosis/therapy
;
Female
;
Fluorescein Angiography
;
Humans
;
Indocyanine Green/diagnostic use
;
Male
;
Middle Aged
;
Retinal Detachment/complications/diagnosis/therapy
;
Retinal Diseases/*complications/diagnosis/therapy
;
Retrospective Studies
;
Risk Factors
;
Visual Acuity
2.Bilateral Serous Retinal Detachment as a Presenting Sign of Acute Lymphoblastic Leukemia.
Jinseon KIM ; Woohyok CHANG ; Min SAGONG
Korean Journal of Ophthalmology 2010;24(4):245-248
We present a case of bilateral serous retinal detachment (SRD) as a presenting sign of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). A 45-year-old woman presented with decreased vision and was found to have bilateral serous retinal detachment. Peripheral blood smears revealed leukocytosis of 53.9x10(3)/microliter with 64.6% lymphoblasts. A bone marrow aspirate revealed the presence of lymphoblasts. Cytogenetic and molecular genetic analysis detected a reciprocal translocation between chromosome 9 and 22, t(9;22) (q34;q11). A diagnosis of Ph+ ALL was made. Following systemic chemotherapy, the bilateral SRD resolved completely with full recovery of vision. The sudden appearance of SRD should raise suspicion for leukemia. Prompt recognition of this disease is important for early systemic treatment and restoration of visual function.
Antineoplastic Agents/therapeutic use
;
Female
;
Fluorescein Angiography
;
Follow-Up Studies
;
Fundus Oculi
;
Humans
;
Middle Aged
;
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*complications/diagnosis/drug therapy
;
Recovery of Function
;
Retinal Detachment/diagnosis/*etiology/physiopathology
;
Tomography, Optical Coherence
;
Visual Acuity/physiology
3.High Dose Intravitreal Bevacizumab for Refractory Pigment Epithelial Detachment in Age-related Macular Degeneration.
Dong Kyu LEE ; Soon Hyun KIM ; Yong Sung YOU ; Oh Woong KWON
Korean Journal of Ophthalmology 2016;30(4):265-271
PURPOSE: Intravitreal anti-vascular endothelial growth factor (anti-VEGF) is the first choice of treatment for age-related macular degeneration. However, quite a few eyes treated using conventional dose anti-VEGF (CDAV) have persistent pigment epithelial detachment (PED) on optical coherence tomography. This study investigated the efficacy and safety of high dose anti-VEGF (HDAV) for refractory PED. METHODS: In this retrospective study, 31 eyes of neovascular age-related macular degeneration patients with persistent PED findings despite six or more intravitreal injections of CDAV (bevacizumab 1.25 mg or ranibizumab 2.5 mg) were analyzed. Changes in visual outcome, central foveal thickness, and PED height were compared before and after HDAV (bevacizumab 5.0 mg) for these refractory PED cases. RESULTS: The mean age of patients was 67.7 years. The number of CDAV injections was 12.1. The number of HDAV injections was 3.39. Best-corrected visual acuity in logarithm of the minimum angle of resolution before and after HDAV was 0.49 and 0.41 (p < 0.001), respectively. Central foveal thickness before and after HDAV was 330.06 and 311.10 µm (p = 0.125), respectively. PED height before and after HDAV was 230.28 and 204.07 µm (p = 0.014), respectively. There were no serious adverse reactions in all the eyes. CONCLUSIONS: Increasing the dose of bevacizumab in refractory PED may be a possible treatment option.
Aged
;
Angiogenesis Inhibitors/administration & dosage
;
Bevacizumab/*administration & dosage
;
Dose-Response Relationship, Drug
;
Female
;
Fluorescein Angiography
;
Fundus Oculi
;
Humans
;
Intravitreal Injections
;
Macular Degeneration/*complications/diagnosis/drug therapy
;
Male
;
Middle Aged
;
Retinal Detachment/diagnosis/*drug therapy/etiology
;
Retinal Pigment Epithelium/*diagnostic imaging/drug effects
;
Retrospective Studies
;
Tomography, Optical Coherence
;
Vascular Endothelial Growth Factor A/antagonists & inhibitors
4.Unilateral neuroretinitis and periparillary serous retinal detachment in cat-scratch disease.
A Osman SAATCI ; F Hakan ONER ; Aydanur KARGI ; Salih KAVUKCU
Korean Journal of Ophthalmology 2002;16(1):43-46
Cat-scratch disease is a self-limited infection characterized by subacute regional lymphadenitis, which is usually preceded by a history of being scratched by a cat infected with the Bartonella species. Neuroretinitis, retinochoroiditis, isolated papillitis and peripapillary angiomatosis are features of posterior segment involvement. However, vision loss is very rare. We report a patient with cat-scratch disease associated with unilateral neuroretinitis and peripapillary serous retinal detachment, and discuss its fluorescein and indocyanine green angiographic features.
Adolescent
;
Animal
;
Anti-Infective Agents/therapeutic use
;
Case Report
;
Cat-Scratch Disease/*complications/diagnosis/therapy
;
Cats
;
Fluorescein Angiography
;
Human
;
Indocyanine Green/diagnostic use
;
Lymph Nodes/pathology
;
Male
;
Retinal Detachment/diagnosis/*etiology/therapy
;
Retinitis/diagnosis/*etiology/therapy
;
Treatment Outcome
;
Trimethoprim-Sulfamethoxazole Combination/therapeutic use
;
Visual Acuity